Delos Reyes, Honeylyn .
HRN: 27-14-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2025
METRONIDAZOLE 500MG (TAB)
06/11/2025
06/17/2025
ORAL
500mg
TID
E. Histolytica
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes